Unlock instant, AI-driven research and patent intelligence for your innovation.

Natural naphthoquinone dimer and its application in the preparation of antibacterial drugs

A naphthoquinone dimer, antibacterial drug technology, applied in the field of pharmacy, can solve serious drug resistance and other problems

Inactive Publication Date: 2018-10-26
FUDAN UNIV
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

It is also because of the wide application of norfloxacin in clinical and animal husbandry that bacteria have developed serious drug resistance to it, thus limiting the application of norfloxacin

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Natural naphthoquinone dimer and its application in the preparation of antibacterial drugs
  • Natural naphthoquinone dimer and its application in the preparation of antibacterial drugs
  • Natural naphthoquinone dimer and its application in the preparation of antibacterial drugs

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0046] Take 1 kg of the roots of Arnebiaeuchroma (purchased from Medicinal Materials Company), crush them, soak and extract with 95% ethanol below 45 degrees Celsius, combine the extracts under reduced pressure and concentrate until all the ethanol has evaporated, add water to the extract and suspend it with acetic acid After extraction with ethyl ester, the organic phase was evaporated to dryness under reduced pressure, and then separated by silica gel and RP-18 forward-reverse phase column chromatography several times to obtain a purple solid compound. Among them, the NMR spectrum data of compounds 2 and 3 are shown in Table 2.

[0047] Table 2. NMR spectrum data of compounds 2 and 3

[0048]

Embodiment 2

[0049] Example 2: Synergistic antibacterial and synergistic effect of EMRSA-16 compound on antibiotics against Staphylococcus aureus

[0050] The synergistic antibacterial test of the compound and antibiotics was carried out at different concentrations formed by the two-fold dilution method on a 96-well plate.

[0051] Dissolve an appropriate amount of norfloxacin in DMSO to prepare an antibiotic mother solution, take an appropriate amount of norfloxacin mother solution and dissolve in the broth to prepare a norfloxacin stock solution, take an appropriate amount of compound sample to dissolve in DMSO to prepare a mother solution, and dilute with the broth. The initial inhibitory concentrations of the compound and the antibiotic were 128 and 256 μg / mL, respectively. An orthogonal experiment was performed to record the concentration of norfloxacin corresponding to each row of microwells where bacteria did not grow. The MIC value of the star. The experimental results are shown in Tab...

Embodiment 3

[0052] Example 3. Direct antibacterial effect of the compound on Staphylococcus aureus

[0053] The standard Staphylococcus aureus strain ATCC25922 and the resistant strains SA1199B, RN4220, EMRSA-15 and Xu212 were taken for microporous antibacterial experiments. The synergistic antibacterial test of the compound and antibiotics was carried out at different concentrations formed by the two-fold dilution method on a 96-well plate. Take an appropriate amount of Norfloxacin and dissolve it in DMSO to prepare an antibiotic mother solution, and take an appropriate amount of Norfloxacin and dissolve it in a broth to prepare a Norfloxacin stock solution. Take an appropriate amount of the compound sample and dissolve it in DMSO to prepare the mother liquor. Diluted with broth, norfloxacin was used as a control drug, and the minimum inhibitory concentration of the compound on the tested strains was greater than 128 μg / mL. None of the compounds showed the activity of inhibiting the growt...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention belongs to the pharmaceutical field, and relates to a natural naphthoquinone dimer and uses of the natural naphthoquinone dimer in preparation of antibacterial drugs. According to the present invention, the compound of the present invention does not have the bacteria growth inhibition effect, and when the compound and antibiotic norfloxacin are subjected to co-administration, the significant synergetic drug-resistant bacteria resistance effect is provided, such that the minimum bacterial inhibition concentration of the antibiotic is reduced by at least 4 times; preferably the bacterial inhibition concentration of the antibiotic is reduced to the 1 / 64 of the single use of the drug; and the compound provides a reverse effect for the experimental norfloxacin-resistant Staphylococcus aureus, and can be adopted as the drug synergist in a monomer or mixture form, such that the drug resistant bacterial resistance drugs can be prepared from the compound and the fluoroquinolone antibiotic. The structure formulas of the compound are defined in the instruction.

Description

Technical field [0001] The invention belongs to the field of pharmacy, and relates to a natural naphthoquinone dimer isolated from Chinese medicinal materials and its use in preparing antibacterial drugs, especially its use in anti-drug resistant Staphylococcus aureus drugs. Background technique [0002] Studies have reported that Methicillin-Resistant Staphylococcusaureus (MRSA) is one of the most common infectious bacteria in hospitals. In addition to superficial skin infections, it can also cause deep human infections. Studies have shown that MRSA, which is resistant to all lactam antibiotics such as penicillin, has also developed resistance to antibiotics such as macrolides, fluoroquinolone, and tetracycline, which makes its infection more difficult treatment. Currently, vancomycin is the only antibiotic that can be used to treat MRSA. Unfortunately, MRSA strains that are fully resistant to vancomycin appeared in the United States in 2002. In recent years in my country, due...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/496A61K31/122A61K31/222A61P31/04
Inventor 穆青叶佳孙仲琳西蒙.吉本斯穆合苏尔.热合曼
Owner FUDAN UNIV